NasdaqCM:CLDXBiotechs
A Look At Celldex Therapeutics (CLDX) Valuation As Shares Show Renewed Momentum
Why Celldex Therapeutics Is On Investors’ Radar
Celldex Therapeutics (CLDX) has recently caught investor attention without a single headline event driving the story. This naturally shifts the focus toward its recent share performance and underlying business profile.
See our latest analysis for Celldex Therapeutics.
At a share price of $30.30, Celldex Therapeutics has seen a 16.4% 90 day share price return and a 52.0% 1 year total shareholder return. This suggests recent momentum has...